
Opinion|Videos|February 5, 2024
Bispecific Therapies: Current and Future Considerations
With their closing thoughts, the panelists provide their key takeaways from this discussion surrounding the operationalization of bispecifics.
Advertisement
The following is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild, PharmD, MS, MBA, CPEL; Kirollos Hanna, PharmD, BCPS, BCOP, FACCC; Sarah Rockwell, PharmD, BCOP; Melody Chang, RPh, MBA, BCOP; and Ryan Cain, PA-C.
Video synopsis is AI-generated and reviewed by AJMC editorial staff.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
GLP-1s More Effective at Preventing Colorectal Cancer Than Aspirin
2
Nimbus Therapeutics, Eli Lilly Partner to Develop Novel Oral Metabolic Drug
3
CDC Vaccine Rollback Highlights Gaps in Public Understanding of Shared Decision-Making
4
Telemedicine Utilization and Preventive Services Among a Rural Population
5



























































